These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8594669)

  • 1. Epidemiological evidence for immunity following Trypanosoma brucei gambiense sleeping sickness.
    Khonde N; Pépin J; Niyonsenga T; Milord F; De Wals P
    Trans R Soc Trop Med Hyg; 1995; 89(6):607-11. PubMed ID: 8594669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire.
    Pepin J; Ethier L; Kazadi C; Milord F; Ryder R
    Am J Trop Med Hyg; 1992 Aug; 47(2):133-40. PubMed ID: 1503182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial aggregation of Trypanosoma brucei gambiense trypanosomiasis in a very high incidence community in Zaire.
    Khonde N; Pépin J; Niyonsenga T; De Wals P
    Trans R Soc Trop Med Hyg; 1997; 91(5):521-4. PubMed ID: 9463655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of familial contamination in Trypanosoma brucei gambiense trypanosomiasis].
    Henry MC
    Bull Soc Pathol Exot Filiales; 1981; 74(1):65-71. PubMed ID: 7296731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human African trypanosomiasis transmission, Kinshasa, Democratic Republic of Congo.
    Simo G; Mansinsa Diabakana P; Kande Betu Ku Mesu V; Manzambi EZ; Ollivier G; Asonganyi T; Cuny G; Grébaut P
    Emerg Infect Dis; 2006 Dec; 12(12):1968-70. PubMed ID: 17326955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo.
    Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V
    Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire.
    Pepin J; Milord F; Mpia B; Meurice F; Ethier L; DeGroof D; Bruneel H
    Trans R Soc Trop Med Hyg; 1989; 83(4):514-7. PubMed ID: 2694491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution of infection by T. brucei gambiense in a population of Bandundu in the Republic of Zaire].
    Henry MC; Ruppol JF; Bruneel H
    Ann Soc Belg Med Trop; 1982 Dec; 62(4):301-13. PubMed ID: 7168586
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.
    Pépin J; Milord F; Khonde AN; Niyonsenga T; Loko L; Mpia B; De Wals P
    Trans R Soc Trop Med Hyg; 1995; 89(1):92-7. PubMed ID: 7747321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
    Milord F; Pépin J; Loko L; Ethier L; Mpia B
    Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma brucei gambiense African trypanosomiasis: differences between men and women in severity of disease and response to treatment.
    Pépin J; Mpia B; Iloasebe M
    Trans R Soc Trop Med Hyg; 2002; 96(4):421-6. PubMed ID: 12497980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priorities for the elimination of sleeping sickness.
    Welburn SC; Maudlin I
    Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.
    Khonde N; Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.
    Pépin J; Milord F; Khonde A; Niyonsenga T; Loko L; Mpia B
    Trans R Soc Trop Med Hyg; 1994; 88(4):447-52. PubMed ID: 7570842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
    De Groof D; Bruneel H; Musumari TS; Ruppol JF
    Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A strategy to control Trypanosomiasis due to Trypanosoma brucei gambiense in an endemic region of Zaire. Association of a serological test and early treatment of suspected cases. Preliminary results].
    De Groof D; Bruneel H; Mungoma K; Ruppol JF
    Bull Soc Pathol Exot; 1993; 86(4):260-3. PubMed ID: 8292915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.
    Pépin J; Khonde N
    Trans R Soc Trop Med Hyg; 1996; 90(2):183-6. PubMed ID: 8761585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
    Kuemmerle A; Schmid C; Bernhard S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete DN; Kisala M; Burri C; Blesson S; Valverde Mordt O
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009903. PubMed ID: 34748572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire.
    Pépin J; Milord F; Meurice F; Ethier L; Loko L; Mpia B
    Trans R Soc Trop Med Hyg; 1992; 86(3):254-6. PubMed ID: 1412646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.